Transatlantic healthcare technologies
NetScientific is a healthcare investment company with a portfolio of digital health, diagnostic, and therapeutic investees. In 2015 the company realigned its investment strategy, bringing a new highly experienced CEO on board, rationalisation of the portfolio and new funding (£18.2m gross from the issue of 15.2m new shares at 120p) to accelerate development in some of its key holdings. A series of value inflection points are expected in 2016 and 2017 including Series A financing for four holdings, the commercial ramp of the Wanda digital health platform, and the launch of the Vortex liquid biopsy product.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.